Paul Bingham and colleagues continue to investigate the wide potential of CPI-613, especially its efficacy when used in concert with other drugs to treat cancer.
Paul Bingham and colleagues continue to investigate the wide potential of CPI-613, especially its efficacy when used in concert with other drugs to treat cancer.
© 2021 Stony Brook University
Get the latest word on Stony Brook news, discoveries and people.